Hong Qi, PhD, LAc

Peking University Third Hospital

PI on 1 trial

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Nephronophthisis
MUC1-related autosomal dominant tubulointerstitial kidney disease

Clinical trials (1)

NCT05604651

Verify independently

ClinicalTrials.gov PI search for Hong Qi, PhD

Other specialists for Nephronophthisis

Peers ranked by clinical-trial PI role, publications, and verification quality.

Lisa Guay-Woodford, MD, MD
Children's Hospital of Philadelphia
DC
Alessandro Flavio Ferri, LAc
Advice Pharma Group S.r.l.
CA
Rémi SALOMON, MD, PhD
Assistance Publique Hopitaux de Paris
Lindsay Baker, PhD
PepsiCo, Inc. Sports Science
Frank van Haren, MD, PhD
St George Hospital, Director of Intensive Care
Li Hui Ping
Shanghai Pulmonary Hospital , Tongji University
Jonnathan Guadalupe Santillán Benítez, MSc
Autonomus University Of the State Of México
Gulsen Akkoc, M.D.
Haseki Training and Research Hospital

See all specialists for Nephronophthisis →

← Back to specialists directory